[Sofosbuvir/ velpatasvir/ voxilaprevir (hepatitis C, 12 to adolescents)

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018004030
German
Original Title: Sofosbuvir/Velpatasvir/Voxilaprevir (chronische Hepatitis C bei Jugendlichen)
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/a21-136.html
Year Published: 2022
URL for published report: https://www.iqwig.de/download/a21-136_sofosbuvir-velpatasvir-voxilaprevir_nutzenbewertung-35a-sgb-v_v1-0.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Hepatitis C
  • Hepatitis C, Chronic
  • Sofosbuvir
  • Antiviral Agents
Keywords
  • Sofosbuvir
  • Velpatasvir
  • Voxilaprevir
  • Adolescent
  • Benefit Assessment
  • NCT03820258
  • Hepatitis C Chronic
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.